New Antidiabetes Medications and Their Cardiovascular and Renal Benefits
This article reviews the major CVOTs that support the use of these agents, describes the mechanisms of action that lead to their broad cardiorenal benefits, explains current guidelines, and offers prac tical clinical advice to initiate and monitor treatment with these agents.
Source: Cardiology Clinics - Category: Cardiology Authors: Enrico G. Ferro, Mohamed B. Elshazly, Deepak L. Bhatt Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart | Heart Disease | Heart Failure | Sodium